The 2021 Akar paper in Journal of Obstetrics and Gynaecology documented anti-proliferative activity of small-molecule NNMT inhibitors in HeLa cell systems (PMID 33645410)
Keine Placebo-Kontrollgruppe, hohes Verzerrungsrisiko hypothesengenerierend, kein Beweis
Can I obtain insurance after qualifying
Because they are new, patented drugs, GLP-1s can cost more than $1,000 per month at their list price
legal status and clinical fit still require review Research products and peptides require careful review of source quality, legality, and supervision
Proposed mechanisms of AOD-9604: Stimulates lipolysis (fat breakdown) Increases fat oxidation Promotes mobilization of stored fat Influences lipid metabolism Importantly, AOD-9604 does not appear to significantly increase growth hormone levels, IGF-1 levels, water retention, or organ growth